Table 3 The prognostic significance of ABO blood type in different subgroups of ENKTL patients
Subgroup | 5-year OS rate (%) | P | |
|---|---|---|---|
Blood type O | Blood type non-O | ||
Ann Arbor stage | |||
 I/II | 66.1 | 53.2 | 0.002 |
 III/IV | 30.6 | 12.1 | 0.151 |
Treatment modality | |||
 CT combined RT | 74.5 | 57.2 | 0.003 |
 CT alone | 37.7 | 30.2 | 0.158 |
 RT alone | 56.7 | 55.5 | 0.352 |
Chemotherapy regimen | |||
 Anthracyclines-containing | 59.4 | 42.8 | 0.010 |
 l-Asparaginase-containing | 80.6 | 62.3 | 0.011 |